Literature DB >> 20826885

A survey of the optical hazards associated with hospital light sources with reference to the Control of Artificial Optical Radiation at Work Regulations 2010.

A Coleman1, F Fedele, M Khazova, P Freeman, R Sarkany.   

Abstract

Workplace exposure to coherent and incoherent optical radiation from artificial sources is regulated under the Artificial Optical Radiation Directive (AORD) 2006/25/EC, now implemented in the UK under the Control of Artificial Optical Radiation at Work Regulations (AOR) 2010. These regulations set out exposure limit values. Implementing the AOR (2010 Health and Safety Statutory Instrument No 1140 www.legislation.gov.uk/uksi/2010/1140/pdf/uksi_20101140_en.pdf) requirements in a hospital environment is a potentially complex problem because of the wide variety of sources used for illumination, diagnosis and therapy. A survey of sources of incoherent optical radiation in a large hospital is reported here. The survey covers examples of office lighting, operating theatre lighting, examination lamps, and sources for ultraviolet phototherapy and visible phototherapies, including photodynamic therapy and neonatal blue-light therapy. The results of the survey are used to inform consideration of the strategy that a hospital might reasonably adopt both to demonstrate compliance with the AOR (2010) and to direct implementation effort.

Mesh:

Year:  2010        PMID: 20826885     DOI: 10.1088/0952-4746/30/3/004

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  2 in total

Review 1.  Photodynamic therapy: occupational hazards and preventative recommendations for clinical administration by healthcare providers.

Authors:  John D Breskey; Steven E Lacey; Benjamin J Vesper; William A Paradise; James A Radosevich; Michael D Colvard
Journal:  Photomed Laser Surg       Date:  2013-07-16       Impact factor: 2.796

Review 2.  Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections.

Authors:  Xiaoqing Hu; Ying-Ying Huang; Yuguang Wang; Xiaoyuan Wang; Michael R Hamblin
Journal:  Front Microbiol       Date:  2018-06-27       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.